Skip to main content

Posts

Showing posts with the label lung cancer

An Affordable and Successful Journey to Lung Transplant in India with Shinon Global

 Lung transplantation is a complex and life-saving procedure for individuals with end-stage lung disease. India has emerged as a leading destination for affordable and successful lung transplant surgeries, offering advanced medical expertise and state-of-the-art facilities. With Shinon Global as your trusted medical tourism partner, you can embark on a transformative journey towards a healthier future. Renowned Medical Expertise: India boasts a pool of highly skilled pulmonologists, thoracic surgeons, and transplant specialists who have gained international recognition for their expertise in lung transplantation. Shinon Global collaborates with prestigious hospitals in India that have dedicated lung transplant programs, ensuring patients receive world-class care from experienced medical professionals throughout their journey. Advanced Facilities and Technology: Shinon Global partners with accredited hospitals in India that are equipped with advanced facilities and cutting-edge tech...

Do you need immunotherapy for advanced-stage lung cancer in India?

 Immunotherapy has emerged as a promising treatment option for advanced-stage lung cancer, particularly for patients with specific biomarkers or those who have not responded well to conventional therapies. Immunotherapy helps stimulate the body's immune system to recognize and attack cancer cells. Immunotherapy is available as a treatment option for advanced-stage lung cancer in India . However, the decision to undergo immunotherapy depends on several factors, including the specific characteristics of the cancer, the patient's overall health, and the recommendations of the treating oncologist. To determine whether immunotherapy is suitable for a patient with advanced-stage lung cancer, the following considerations are typically taken into account: 1. Biomarker Testing: Immunotherapy is most effective in lung cancer patients with specific biomarkers, such as PD-L1 expression or the presence of certain genetic mutations (e.g., EGFR, ALK, ROS1). Biomarker testing is conducted to ...